In a new study, the drug, deucravacitinib, proved to be a safe and more effective treatment for cutaneous lupus erythematosus ...

Middlemen get a bad rap for adding cost and complications to an operation. So, eliminating the go-betweens can reduce expense ...

PERSPECTIVES: The resurgence of Y2K skin-baring fashion trends coincides with the rise of prescription weight loss drugs like ...

The first medical treatment to use Crispr gene editing has been on the market for a year. Its complexity means few patients ...

Extracellular vesicles (EVs) have emerged as a transformative platform in biomedical research, especially in the domains of diagnosis, prophylaxis, and ...

Experiments that make viruses more virulent or contagious present significant risks. Are those risks worth the rewards?

When the Dalai Lama went to New York in June for knee surgery, his followers worried about his overall health and the future ...

A breakthrough in understanding how a single-cell parasite makes ergosterol (its version of cholesterol) could lead to more ...

What we can glean from the pattern of accidental discoveries in science, especially in the pharmaceutical industry, and their ...

James Dahlman and his research team have been thinking along those same lines for stem cell treatments. They’ve created a ...

Paleogenomics has finally solved a question that has puzzled researchers for decades: Where did syphilis come from?

Discussing the tradeoffs in public-health decisions might help us make better choices, write Dr. Christopher Worsham and Dr.